Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Eris Lifesciences Ltd.
NSE: ERIS
|
BSE: 540596
|
ISIN: INE406M01024
|
Industry: Pharmaceuticals
|
Mid-range Performer
1699.2000
-14.50
(
-0.85
%)
NSE
Sep 11, 2025
15:31 PM
54.87% Gain from 52W Low
Volume:
43,002
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Eris Lifesciences Ltd.
05 May 2022
1699.20
-0.85%
In line 4QFY22 at the operational level; geared up for launches in FY23
Buy:
Eris Lifesciences Ltd.
by
Motilal Oswal
Target: 870
Motilal Oswal
Number of FII/FPI investors increased from 178 to 193 in Jun 2025 qtr.
More from Eris Lifesciences Ltd.
Recommended
Market closes higher, Tega Industries to buy Molycop with Apollo Funds in a $1.5 bn deal
Trendlyne Marketwatch |
11 Sep 2025, 04:07PM
India’s IPO story in 2025: Investors go selective, backing quality over hype
The Baseline |
11 Sep 2025, 03:50PM
Earnings Call Transcript - Q1FY21 for Eris Lifesciences
|
04 Aug 2020